Lambert–Eaton myasthenic syndrome is a rare autoimmune disorder characterised by muscle weakness of the limbs. Around 60% of those with LEMS have an underlying malignancy, most commonly small-cell lung cancer; it is therefore regarded as a paraneoplastic syndrome.